The U.S. Food and Drug Administration (FDA) approves a new drug to treat kidney cancer.

The drug Nexavar, made by German drugmaker Bayer AG and Onyx Pharmaceuticals Inc., can help curb the size and number of tumors in the most common form of kidney cancer, but has yet to make an impact on the length of life of the patients

A $10 billion class-action lawsuit against Altria Group Inc.'s Philip Morris USA division is thrown out by the Illinois Supreme Court, ruling the maker of Marlboros and other brands did not defraud customers in its marketing of "light" cigarettes.

The court reversed the verdict and sent the case back to Madison County court with the order to dismiss the matter. According to the Supreme Court, in a divided decision, the Federal Trade Commission specifically allowed companies to characterize their cigarettes as "light" and "low tar," so Philip Morris did not improperly mislead customers about the health impacts of its cigarettes. The cigarette maker argues the case should never have been declared a class-action on behalf of some 1.1 million light cigarette smokers who have not accused the company of harming their health

It was a bad run as Shayna Richardson made her first solo skydive jump, which ended with her falling at 50 mph and landing face- first in a parking lot.

She miraculously survived and while doctors treated her, they discovered she was pregnant

Diabetes is known as a costly disease because of high medical expenses and lost wages, which a recent study claims is infecting the local economy.

Numerous studies have analyzed the direct and indirect costs of diabetes at the national level. A study conducted by several universities in Texas investigated for the first time the financial impact of diabetes upon local communities. The study concludes that for every $1 of lost income due to diabetes, another 36 cents is lost in reduced local spending

The not-for-profit National Women's Health Resource Center (NWHRC) today announced the results of a national survey of more than 600 women who experience excessive menstrual bleeding, diagnosed as referred to as menorrhagia. The survey found that most women (58 percent) have not discussed their condition with a healthcare provider, despite the fact that menorrhagia greatly impacts their lives and is easily treated.

Excessive menstrual bleeding is a debilitating health condition 10 million women in the US suffer from. Although menorrhagia is not fatal, women with the condition face a number of devastating effects, from fatigue and anemia, caused by the extreme loss of blood, to embarrassing accidents and restricted activity that wreak havoc on personal and professional lives. One in five women surveyed missed one week of work or more in the past year due to this condition